These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 1243924)

  • 1. [Experiment compared between iodoxamidic acid and ioglycamic acid, in flasks drop by drop. Observations of adverse reactions].
    Viviani G; Mozzanica C; Pozzoli P
    J Radiol Electrol Med Nucl; 1975; 56 suppl 2():548. PubMed ID: 1243924
    [No Abstract]   [Full Text] [Related]  

  • 2. [Injection cholecystography--influence of radiopaque substance and injection time on the excretion of contrast media and incidence of side effects].
    Schmerwitz W
    Rontgenblatter; 1977 Feb; 30(2):64-70. PubMed ID: 576504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study of intravenous cholangio-cholecystography with a meglumine salt of iodoxamic acid with research on fibrinolysis].
    Macchi C; Fiore D; Miotto D; Cella G; Bidoli F
    J Radiol Electrol Med Nucl; 1975; 56 suppl 2():549-50. PubMed ID: 1243925
    [No Abstract]   [Full Text] [Related]  

  • 4. [Influence of radiopaque substance and concentration of contrast media as well as time of infusion on excretion of contrast medium and incidence of side effects (author's transl)].
    Schmerwitz W; Rösch E
    Rontgenblatter; 1977 Feb; 30(2):71-8. PubMed ID: 576505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse reactions to intravenous cholangiography with Biligram.
    Hald JK
    Eur J Radiol; 1984 Aug; 4(3):196-7. PubMed ID: 6468411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A contribution to the rate of side-effects of hepatotropic contrast media. A clinical comparative study of iodoxamate (Endomirabil) and ioglycamid (Bilivistan) (author's transl)].
    Kölling K; Hoenle R; Korsten FW
    Radiologe; 1977 Feb; 17(2):70-3. PubMed ID: 322198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and toleration of the non-ionic contrast medium iopentol. An intravenous phase I trial.
    Jakobsen JA; Hagve TA; Holager T; Waaler A; Haider T; Andrew E; Aakhus T
    Eur J Radiol; 1989 Nov; 9(4):203-7. PubMed ID: 2591384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical experiences with iodoxamic acid in the cholecystography-cholangiography (author's transl)].
    Keiner F
    Med Klin; 1976 Oct; 71(44):1885-90. PubMed ID: 1036604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Intravenous cholangiocholecystography using ioglycamide--indications and value].
    Wujciak D; Weingärtner R; Illmann E; Baars HG
    Radiol Diagn (Berl); 1990; 31(3):247-51. PubMed ID: 2367630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Endomirabil, a new contrast medium for the biliary tract. Rate of adverse effects with special reference to the application time].
    Barner L; Kurzen S
    Med Welt; 1977 Apr; 28(17):817-9. PubMed ID: 577589
    [No Abstract]   [Full Text] [Related]  

  • 11. [Modern X-ray contrast media applicable to intravenous cholangiocholecystography (review of the literature)].
    Sviridov NK; Popova ZP; Varfolomeeva VN; Mikhaĭlova NA
    Farmakol Toksikol; 1981; 44(2):245-7. PubMed ID: 7023971
    [No Abstract]   [Full Text] [Related]  

  • 12. Intravenous contrast media in Waldenströms macroglobulinaemia and related disorders: a potentially harmful investigation?
    Dammacco F; Valente A; Fucci G; Buonanno G
    Haematologica; 1977 Jun; 62(3):279-87. PubMed ID: 408241
    [No Abstract]   [Full Text] [Related]  

  • 13. [Intravenous cholegraphy with Chologram (a double blind comparison with Bilivistan) (author's transl)].
    Taenzer V; Blumenbach L; Heitzeberg H; Kolb KH; Speck U; Wolf R
    Rofo; 1975 Nov; 123(5):414-8. PubMed ID: 128498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased pain reactions as hang-over phenomena after intra-arterial injections of contrast media in rats.
    Hagen B; Siefert HM; Mützel W; Speck U
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1983; 118():57-61. PubMed ID: 6139081
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cholecystocholangiography in children].
    Orlandini I; Aimi G
    J Radiol Electrol Med Nucl; 1975; 56 suppl 2():550-2. PubMed ID: 1243926
    [No Abstract]   [Full Text] [Related]  

  • 16. [A new bile contrast in pediatrics (author's transl)].
    Fahr K; Oppermann HC; Willich E
    Monatsschr Kinderheilkd (1902); 1978 Jun; 126(6):391-4. PubMed ID: 661834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New contrast media for angiography (Telebrix, Hexabrix) (author's transl)].
    Bohutová J; Kolár J; Karmazin V; Stupáková Z
    Cas Lek Cesk; 1981; 120(50):1527-30. PubMed ID: 7326714
    [No Abstract]   [Full Text] [Related]  

  • 18. Contrast media and pain: hypotheses on the genesis of pain occurring on intra-arterial administration of contrast media.
    Hagen B; Klink G
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1983; 118():50-6. PubMed ID: 6139080
    [No Abstract]   [Full Text] [Related]  

  • 19. Intravenous cholangiography, is technique important?
    Bell GD; Fayadh MH; Frank J; Smith PL; Kelsey-Fry I
    Gut; 1975 Oct; 16(10):841. PubMed ID: 1205325
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cholangiography and cholecystography with a new water-soluble contrast medium (BC-17) by intravenous drip infusion (II). Effects on tests of thyroid function (author's transl)].
    Tanimura H; Ishii K; Fujimura M; Matsuda M
    Nihon Geka Hokan; 1974 Nov; 43(6):476-85. PubMed ID: 4480399
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.